Form D · Biotechnology

Magnus Medical, Inc.

Burlingame, CA · CIK 0002057312

Offering snapshot reported May 26, 2026 · SEC filing

Reported sold: $49M
Investors reported: 10
Minimum accepted: $0
First sale: May 1, 2025

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$23,683,674 → $49,030,035
Reported investors6 → 10

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 26, 2026	Amendment	$49,030,035	$25,346,361vs May 12, 2025	10	SEC filing
May 12, 2025	Initial	$23,683,674	No comparison	6	SEC filing
Mar 14, 2025	Initial	$40,302,337	No comparison	10	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-545714

Source: Form D, filed May 26, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Achal Achrol	Director, Executive
Brandon Bentzley	Director, Executive
Xingjuan Chao	Director
Andrew Firlik	Director
Christian Gormsen	Director, Executive
Vikram Lamba	Executive
Heath Lukatch	Director
Nolan Williams	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

1350 Old Bayshore Hwy, Suite 600
Burlingame, CA, 94010